Tumor exosomes can also deliver epidermal growth factor receptor (EGFR) to host macrophages, inhibiting the production of type I interferons and thereby reducing the overall immune response in cancer patients (Gao et al., 2018). The gene discussed is EGFR; the disease is neoplasm.